CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Venmax Drugs and Pharmaticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Venmax Drugs and Pharmaticals Ltd
Shed No.22
Plot No.84, Phase - 1, IDA Cherlapally
Phone: +91 4020000415p:+91 4020000415 HYDERABAD, 500055  India Ticker: 531015531015
Business Summary
Venmax Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of pharmaceutical products, drug intermediaries and active pharmaceutical ingredients (API’s). It is developing oncology products through research and development (R&D).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20253/31/2024-----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Additional Whole Time Director Venkata R.Sadhanala 10/1/2024 10/1/2024
Additional Non-Executive Non-Independent Director SwapneswarMishra 44 1/16/2024 1/16/2024
Additional Non-Executive Non-Independent Director Dasi R.Rakesh 36 8/22/2024 8/22/2024
Additional Non-Executive Independent Director Pilli M.Kumari 57 1/16/2024 1/16/2024
Additional Non-Executive Independent Director GundluruReddappa 41 8/22/2024 8/22/2024

General Information
Outstanding Shares: 5,238,930 (As of 3/31/2025)
Stock Exchange: BOM
Fax Number: +91 403735177


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 23, 2025